Location History:
- Chiyoda-ku, JP (2014)
- Tokyo, JP (2015)
Company Filing History:
2 out of 35,756 
2 out of 11 Years Active: 2014-2015
Title: Takayuki Mizutani: Innovator in Cancer Marker Research
Introduction
Takayuki Mizutani is a prominent inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of cancer research, particularly in the development of novel cancer markers. With a total of 2 patents to his name, Mizutani's work is paving the way for advancements in cancer evaluation methods.
Latest Patents
Mizutani's latest patents focus on a cancer marker and a method for evaluating cancer using this marker. The invention provides a novel cancer marker that can assess the onset, preclinical stage, clinical stage, or prognosis of cancer in a subject. This cancer marker includes at least one miRNA selected from hsa-miR-92 and hsa-miR-494, specifically for cancers excluding breast cancer. The evaluation method involves detecting the expression level of the cancer marker in a biological sample collected from a subject.
Career Highlights
Throughout his career, Mizutani has worked with notable organizations such as NEC Corporation and Tokyo Medical University. His experience in these institutions has contributed to his expertise in cancer research and innovation.
Collaborations
Mizutani has collaborated with esteemed colleagues, including Masahiko Kuroda and Masami Tanaka. These partnerships have further enhanced his research and development efforts in the field of cancer markers.
Conclusion
Takayuki Mizutani's innovative work in cancer marker research demonstrates his commitment to improving cancer evaluation methods. His contributions are vital in the ongoing fight against cancer, and his patents reflect the potential for significant advancements in this critical area of healthcare.